Global Fish Oil EPA and DHA Market Insights, Forecast to 2031

The global Fish Oil EPA and DHA market is projected to grow from US$ 1,624.90 million in 2024 to US$ 2,020.84 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.37% during the forecast period (2025-2031).

The US & Canada market for Fish Oil EPA and DHA is estimated to increase from US$ 585.45 million in 2024 to reach US$ 683.37 million by 2031, at a CAGR of 2.57% during the forecast period of 2025 through 2031.

The China market for Fish Oil EPA and DHA is estimated to increase from US$ 373.56 million in 2024 to reach US$ 524.95 million by 2031, at a CAGR of 5.03% during the forecast period of 2025 through 2031.

The Europe market for Fish Oil EPA and DHA is estimated to increase from US$ 358.13 million in 2024 to reach US$ 428.79 million by 2031, at a CAGR of 2.80% during the forecast period of 2025 through 2031.

The global key manufacturers of Fish Oil EPA and DHA include KD Pharma, Croda, BASF, Yuwang Pharma, GC Rieber VivoMega, Pelagia (EPAX), Golden Omega, TASA, KinOmega Biopharm, Omega Protein, Huatai Phrama, AlaskOmega (Wiley Companies), Jiangsu Auqi Marine Biotechnology, Sinomega Biotech Engineering, Xinzhou Marine Biological Products, Nu-Mega (Clover), Skuny Bioscience, Renpu Pharmaceuticals, Polaris, Solutex, etc. In 2024, the global top five players had a share approximately 45.28% in terms of revenue.

In terms of production side, this report researches the Fish Oil EPA and DHA production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2024, and forecast to 2031.

In terms of consumption side, this report focuses on the sales of Fish Oil EPA and DHA by region (region level and country level), by company, by Type and by Application. from 2020 to 2024 and forecast to 2031.

This report presents an overview of global market for Fish Oil EPA and DHA, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2024, estimates for 2024, and projections of CAGR through 2031.

This report researches the key producers of Fish Oil EPA and DHA, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Fish Oil EPA and DHA, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Fish Oil EPA and DHA sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2024. Identification of the major stakeholders in the global Fish Oil EPA and DHA market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Fish Oil EPA and DHA sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including KD Pharma, Croda, BASF, Yuwang Pharma, GC Rieber VivoMega, Pelagia (EPAX), Golden Omega, TASA, KinOmega Biopharm, Omega Protein, Huatai Phrama, AlaskOmega (Wiley Companies), Jiangsu Auqi Marine Biotechnology, Sinomega Biotech Engineering, Xinzhou Marine Biological Products, Nu-Mega (Clover), Skuny Bioscience, Renpu Pharmaceuticals, Polaris, Solutex, etc.

Market Segmentation

By Company

• KD Pharma
• Croda
• BASF
• Yuwang Pharma
• GC Rieber VivoMega
• Pelagia (EPAX)
• Golden Omega
• TASA
• KinOmega Biopharm
• Omega Protein
• Huatai Phrama
• AlaskOmega (Wiley Companies)
• Jiangsu Auqi Marine Biotechnology
• Sinomega Biotech Engineering
• Xinzhou Marine Biological Products
• Nu-Mega (Clover)
• Skuny Bioscience
• Renpu Pharmaceuticals
• Polaris
• Solutex

Segment by Type

• Fish Oil DHA
• Fish Oil EPA

Segment by Application

• Dietary Supplements
• Fortified Food and Beverages
• Infant Formula
• Pharmaceuticals
• Pet Food
• Others

Production by Region

• North America
• Europe
• China
• South America

Sales by Region

US & Canada

• U.S.
• Canada

China

Asia (excluding China)

• Japan
• South Korea
• Southeast Asia
• India

Europe

• Germany
• France
• U.K.
• Italy
• Nordic Countries

Latin America

• Brazil
• Mexico
• Argentina
• Peru

Middle East and Africa

• Middle East
• Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Fish Oil EPA and DHA production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of Fish Oil EPA and DHA in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Fish Oil EPA and DHA manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: China by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 11: Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.

Chapter 13: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fish Oil EPA and DHA sales, revenue, price, gross margin, and recent development, etc.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 16: The main points and conclusions of the report. Show more